Operating profit before deduction of amortization: XTL Biopharmaceuticals Ltd. (XTLB)
The EBITDA_Co chart illustrates daily operating profit dynamics, where 0.00 captures the current state of the parameter. Volatility is driven by disruptions in biomaterial logistics and sanctions hindering drug certification. A capital deficit is forcing XTL Biopharmaceuticals (XTLB) to cautiously acquire new assets while avoiding price wars. The scaling strategy is based on licensing formulas for autoimmune diseases, which eliminates the need for manufacturing plant expenditures.
XTL Biopharmaceuticals Ltd. (XTLB) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio XTL Biopharmaceuticals|XTLB - Long-Term Debt to Capital|Current Liabilities to Capital XTL Biopharmaceuticals Ltd|XTLB - Company Total Debt|Debt to Book Value Ratio XTL Biopharmaceuticals|XTLB - Company Long-Term Liabilities|Amount of Current Liabilities XTL Biopharmaceuticals|Quick Liquidity xtlbio.com
- earnings and multiples data:
XTLB - Net Income|Expected Net Income XTL Biopharmaceuticals|XTLB - P/E Multiple|Future Price to Earnings xtlbio.com|XTLB - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio XTL Biopharmaceuticals|XTLB - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months XTL Biopharmaceuticals|XTLB - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months xtlbio.com|XTLB - Earnings growth in current year|Expected earnings per share trend next year XTL Biopharmaceuticals
Fundamental company valuation:XTL Bio - XTLB
To select assets with a high margin of safety, analyzing EBITDA is critically important. This indicator measures the real ability of XTL Biopharmaceuticals (XTLB) to generate cash, confirming the effectiveness of ESG standard implementation and the optimization of biochemical production, while actual operating profit serves as a signal for entering or exiting a position.
Competitor analysis for XTL Biopharmaceuticals
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX: Operating profit before deduction of amortization|VERA (Vera Corp) - Operating profit before amortization|DNTH (Dianthus Therapeutics) - Operating profit before deduction of amortization|PHVS: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Profit before payment of interest, taxes and amortization TRML|Operating profit before deduction of amortization PGEN (Intrexon)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|upstreambio.com - Profit before payment of interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|Operating income before deduction of amortization Immunome Inc IMNM|Gossamer Corp (GOSS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization KalVista Corp (KALV)|Profit before payment of interest, taxes and amortization Septerna Inc|pieris.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SVRA|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANAB (AnaptysBio Corp)|Operating profit EBITDA Astria Corp ATXS|ENGN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Aclaris Therapeutics Inc.|KYTX (Kyverna) - Operating profit EBITDA|Operating profit EBITDA Tiziana Life Sciences, Ltd.|Operating profit EBITDA CABA|Operating profit before deduction of amortization ventyxbio.com VTYX|Operating profit EBITDA THTX (Theratechnologies)|Avalo Therapeutics, Inc. (AVTX) - Profit before interest, taxes and amortization|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|CLYM (Climb Bio Inc) - Operating profit before deduction of amortization|ZURA: Company profit before taxes, interest and amortization|ATYR (aTyr Pharma) - Operating profit EBITDA|Adagene Corp (ADAG) - Operating income before deduction of amortization|Operating profit EBITDA IMA|Operating profit before deduction of amortization shattucklabs.com STTK|Operating profit EBITDA EQ (Equillium)|Operating profit EBITDA Connect Biopharma Holdings CNTB|IMUX - Profit before payment of interest, taxes and amortization|ATRA: Profit before payment of interest, taxes and amortization|inflarx.de (IFRX) - Profit before payment of interest, taxes and amortization|XFOR - Operating income before deduction of amortization|Operating profit before deduction of amortization ACET|Operating profit before amortization CELU (Celularity Corp)|Operating profit before deduction of amortization INMB (INmune Bio)|Company profit before taxes, interest and amortization BRNS|Profit before payment of interest, taxes and amortization Kezar Life Sciences, Inc KZR|SAB Biotherapeutics Inc - Profit before payment of interest, taxes and amortization|Akari Therapeutics - Operating profit EBITDA|ENLV: Profit before payment of interest, taxes and amortization|q32bio.com (QTTB) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization GOVX (GeoVax Labs)|EDSA (Edesa) - Operating profit EBITDA|IBIO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CARM|Operating profit EBITDA boltbio.com (BOLT)|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|Income before deduction of interest, taxes and amortization APVO|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI: Operating profit EBITDA|xortx.com (XRTX) - Operating profit EBITDA|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating income before deduction of amortization BiondVax Pharmaceuticals|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD - Operating profit before deduction of amortization|ALLK - Profit before payment of interest, taxes and amortization|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS (igmbio.com) - Operating profit before deduction of amortization|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|Operating profit before amortization TCBP (tcbiopharm.com)|Operating profit EBITDA THRD
